Free Trial

Profound Medical (PROF) Earnings Date, Estimates & Call Transcripts

Profound Medical logo
$6.70 -0.12 (-1.69%)
As of 12:02 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Profound Medical Latest Earnings Summary

Upcoming Q1
Earnings Date
May. 8After Market ClosesEstimated
Actual EPS
(Mar. 6)
-$0.20 Beat By $0.11
Consensus EPS
(Mar. 6)
-$0.31

Profound Medical released Q4 2024 earnings on March 6, 2025, reporting an EPS of -$0.20, which topped analysts' consensus estimates of -$0.31 by $0.11. Quarterly revenue was reported to be $4.18 million, below analyst estimates of $5.92 million. With a trailing EPS of -$1.12, Profound Medical's earnings are expected to grow next year, from ($1.12) to ($0.78) per share.

PROF Upcoming Earnings

Profound Medical's next earnings date is estimated for Thursday, May 8, 2025, based off prior year's reporting schedules.

Get Profound Medical Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Profound Medical and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

PROF Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PROF Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Remove Ads

Profound Medical Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.26-$0.26-$0.26
Q2 20251-$0.26-$0.26-$0.26
Q3 20251-$0.26-$0.26-$0.26
Q4 20251-$0.26-$0.26-$0.26
FY 20254-$1.04-$1.04-$1.04
Q1 20261-$0.24-$0.24-$0.24
Q2 20261-$0.20-$0.20-$0.20
Q3 20261-$0.19-$0.19-$0.19
Q4 20261-$0.14-$0.14-$0.14
FY 20264($0.77)($0.77)($0.77)
Remove Ads

Profound Medical Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/8/2025
(Estimated)
-------
3/6/2025Q4 2024-$0.31-$0.20+$0.11-$0.20$5.92M$4.18M
11/7/2024Q3 2024-$0.33-$0.38 -$0.05-$0.38$3.30M$2.83M
8/8/2024Q2 2024-$0.28-$0.28--$0.28$2.50M$2.23M
5/9/2024Q1 2024-$0.31-$0.26+$0.05-$0.26$2.40M$1.91M
3/7/2024Q4 2023-$0.28-$0.42 -$0.14-$0.42$1.90M$2.01M
11/2/2023Q3 2023-$0.32-$0.26+$0.06-$0.26$2.40M$1.73M
8/9/2023Q2 2023-$0.31-$0.35 -$0.04-$0.35$2.05M$1.60M
5/10/2023Q1 2023-$0.38-$0.32+$0.06-$0.32$1.85M$1.86M

Profound Medical Earnings - Frequently Asked Questions

Profound Medical has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on PROF's earnings history.

Profound Medical updated its FY 2024 earnings guidance on Wednesday, January, 8th. The company issued revenue guidance of $11.1 million-$11.2 million, compared to the consensus revenue estimate of $15.9 million.

In the previous quarter, Profound Medical (NASDAQ:PROF) reported ($0.20) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.31) by $0.11. Learn more on analysts' earnings estimate vs. PROF's actual earnings.

The conference call transcript for Profound Medical's latest earnings report can be read online.
Read Transcript

Profound Medical (NASDAQ:PROF) has a recorded annual revenue of $10.68 million.

Profound Medical (NASDAQ:PROF) has a recorded net income of -$28.57 million. PROF has generated -$1.12 earnings per share over the last four quarters.

Profound Medical's earnings are expected to grow from ($1.12) per share to ($0.78) per share in the next year.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:PROF) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners